Clinical Trials
28 trialsCombining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck
Eastern Cooperative Oncology Group
Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck
Eastern Cooperative Oncology Group
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
Eastern Cooperative Oncology Group
ADHERE
European Organisation for Research and Treatment of Cancer - EORTC
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
Radiation Therapy Oncology Group
Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
Radiation Therapy Oncology Group
Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer
Radiation Therapy Oncology Group
Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
Radiation Therapy Oncology Group
Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
Canadian Cancer Trials Group
Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
Radiation Therapy Oncology Group
Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx
European Organisation for Research and Treatment of Cancer - EORTC
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
European Organisation for Research and Treatment of Cancer - EORTC
Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer
Radiation Therapy Oncology Group
Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
Radiation Therapy Oncology Group
S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
SWOG Cancer Research Network
Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
Radiation Therapy Oncology Group
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Radiation Therapy Oncology Group
Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer
Radiation Therapy Oncology Group
Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
Radiation Therapy Oncology Group
Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck
Radiation Therapy Oncology Group
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
Radiation Therapy Oncology Group
S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx
SWOG Cancer Research Network
Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC
S9709, Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the Larynx
SWOG Cancer Research Network
S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat
SWOG Cancer Research Network
S0217
SWOG Cancer Research Network
S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer
SWOG Cancer Research Network